Loading...

Generation and evaluation of a monoclonal antibody, designated MAdL, as a new specific marker for adenocarcinomas of the lung

BACKGROUND: Different therapy regimens in non-small-cell lung cancer (NSCLC) are of rising clinical importance, and therefore a clear-cut subdifferentiation is mandatory. The common immunohistochemical markers available today are well applicable for subdifferentiation, but a fraction of indistinct c...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Schultz, H, Marwitz, S, Baron-Lühr, B, Zissel, G, Kugler, C, Rabe, K F, Zabel, P, Vollmer, E, Gerdes, J, Goldmann, T
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188931/
https://ncbi.nlm.nih.gov/pubmed/21811254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.281
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!